IDSA Response to Pfizer Request for COVID-19 Vaccine EUA

Barbara D. Alexander, M.D., MHS, FIDSA – President, Infectious Diseases Society of America on today’s Pfizer/BioNTech application for Emergency Use Authorization of its COVID-19 vaccine candidate: While encouraging data from the Pfizer/BioNTech COVID-19 vaccine trial indicates the welcome possibility of a critical new tool against the pandemic, a…

Read the full article here

Related Articles